NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 18, 2026 (GLOBE NEWSWIRE) — Apex Critical Metals Corp. (CSE: APXC) (OTCQX: APXCF) (FWB: KL9) (“Apex” or the “Company”), a Canadian mineral exploration company focused on the identification and development of critical and strategic metals, announces that it has entered into an agreement with Canaccord Genuity Corp. to act as lead agent and sole bookrunner along with a syndicate of agents to be formed (the “Agents”) in connection with a “best efforts” private placement of up to 5,264,000 units of the Company (each, a “Unit”, and, collectively, the “Units”) at a price of C$1.90 per Unit (the “Offering Price”) for aggregate gross proceeds of up to C$10,001,600 (the “Offering”) under the Listed Issuer Financing Exemption...

EAGLE, Idaho, May 18, 2026 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2026 RBC Global Healthcare Conference on May 20, 2026. John Gochnour, President and Chief Operating Officer, Lynette Walbom, Chief Financial Officer, and Andy Rider, President of Senior Living, will participate in a fireside chat on May 20, 2026 at 9:30 a.m. Eastern Time. A live webcast of the event will be accessible at https://kvgo.com/rbc/the-pennant-group-inc-may-2026. About Pennant: The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through home health and hospice agencies and senior living communities located throughout...

PHILADELPHIA, PA, May 18, 2026 (GLOBE NEWSWIRE) — Exyn Technologies, Inc. (“Exyn” or the “Company”) (NASDAQ: EXYN, EXYNW), a leader in autonomous mapping and perception-driven navigation for complex, GPS-denied environments, today announced the closing of its initial public offering (the “Offering”) of 2,500,000 units, with each unit consisting of one share of its common stock (the “Common Stock”) and one warrant to purchase one share of its common stock (the “Warrants”) at a public offering price of $7.75 per unit. The shares of Common Stock and Warrants began trading on the Nasdaq Capital Market on May 15, 2026, under the ticker symbols “EXYN” and “EXYNW,” respectively. The aggregate gross proceeds from the Offering, before deducting underwriting discounts and commissions and other offering expenses payable by Exyn, were approximately $19.4...

PHOENIX, May 18, 2026 (GLOBE NEWSWIRE) — Global Water Resources Inc., (“the Company”), (NASDAQ: GWRS), a pure-play water resource management company, announced that the nominees listed in the Proxy Statement, dated March 31, 2026, for the 2026 Annual Meeting of Stockholders (“the Meeting”) were selected as Directors of the Company. As of the March 17, 2026 record date for the determination of the shareholders entitled to notice of and to vote at the meeting, 28,763,634 shares of common stock were outstanding and eligible to vote. A total of 24,858,154 shares were voted in person or by proxy at the meeting. The results of the vote for the election of the Directors at the Meeting were as follows:  Votes For % of Total Shares Voted(1) Votes Withheld % of Total Shares Voted(1) Broker Non-VotesRon L. Fleming 18,859,704 94.97% 998,259 5.03% 5,000,191Richard...

HOUSTON, May 18, 2026 (GLOBE NEWSWIRE) — Intuitive Machines, Inc. (Nasdaq: LUNR) (“Intuitive Machines”, together with its subsidiaries, the “Company”), a space technology, infrastructure, and services leader, is now the prime contractor for operations of the Lunar Reconnaissance Orbiter Camera (“LROC”), a key instrument aboard NASA’s Lunar Reconnaissance Orbiter (“LRO”), and the ShadowCam instrument, a specialized lunar imaging camera on board the Korea Pathfinder Lunar Orbiter that provides visibility in light obscured conditions such as dark and shadowed regions of the Moon.Pictured: LROC-sourced high-resolution image of the Moon’s Reiner Gamma region, which is one of the most distinctive and enigmatic features on the Moon. Reconnaissance images like these will help navigate Intuitive Machines’ IM-3...

Data reinforce WVE-006’s potential to address both lung and liver manifestations of AATD with a durable, convenient, and safe therapy capable of recapitulating the protective MZ-like phenotype with monthly dosing  On track for feedback from FDA on potential accelerated approval pathway mid-2026 WVE-006 generated wild-type M-AAT comprising 64% of total AAT and reduced harmful Z-AAT by 71%, with 11.9 µM total AAT in the 200 mg biweekly cohort; effects were consistent with 400 mg monthly dosing regimen, with 13.6 µM total AAT; editing was sustained at least three months following last dose Restored dynamic AAT production with two new observations of elevated AAT during acute phase responses following mild upper respiratory infections, building on prior observation of 20.6 µM of total AAT during an acute phase response two weeks post-single...

LITTLETON, Mass., May 18, 2026 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (Nasdaq: POCI) (the “Company”), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026. Company WebcastThe webcast presentation will take place at 1:00 p.m. ET on Thursday, May 28, 2026. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2026/ or directly at https://app.webinar.net/Ka2bMmgyojv. The webcast will also be available for replay following the event. 1×1 MeetingsManagement will be participating in virtual one-on-one meetings...

RESEARCH TRIANGLE PARK, N.C., May 18, 2026 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced that on May 11, 2026, the Compensation Committee of the Company’s Board of Directors approved the grant of stock option awards (“Stock Options”) to purchase an aggregate of 50,000 of the Company’s common shares to three new non-executive employees of the Company with a grant date of May 18, 2026 under the Company’s 2026 Equity Inducement Plan (the “Inducement Plan”). The Stock Options consist of incentive stock options to purchase an aggregate of 49,141 shares and nonqualified stock options to purchase an aggregate of 859 shares. The Stock Options were granted as inducements material to the employees entering into employment with the Company...